Personas Announces Full Revocation of Cease Trade Order and Provides Update on Reinstatement of Trading on the TSXV
Toronto, Ontario–(Newsfile Corp. – February 13, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“)…
Toronto, Ontario–(Newsfile Corp. – February 13, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company“)…
BEVERLY, Mass.–(BUSINESS WIRE)–Easterly Asset Management (“Easterly”), a multi-affiliate asset manager of high-performing boutique investment firms,…
Eligible individuals can earn in-demand healthcare certifications and credit toward a Trine University degree ANGOLA,…
CHAPEL HILL, North Carolina–(BUSINESS WIRE)–Ultisim issued an open letter to Mark Zuckerberg today with a…
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
TORONTO and TEL AVIV, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV:…
TORONTO and TEL AVIV, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV:…
Topline trial results expected mid-March 2023 NEWTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Acer…
Topline trial results expected mid-March 2023 NEWTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Acer…
Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform CVN424 for Parkinson’s…
Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETSseq platform CVN424 for Parkinson’s…
MINNEAPOLIS, Minn, Feb. 13, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a…
MINNEAPOLIS, Minn, Feb. 13, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a…
– Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on…
– Q-Code assigned to CIMERLI® for Medicare claims processing effective for dates of service on…
CAMBRIDGE, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical…
TULSA, Okla.–(BUSINESS WIRE)–Williams (NYSE: WMB) today announced that its Board of Directors has appointed Carri…
— Post hoc analyses found a statistically significant reduction in the duration of flu infection…
SAN DIEGO, Feb. 13, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…